Sorry, you need to enable JavaScript to visit this website.
Skip to content

////// Science for a better life

  • Global
  • Media/Press
  • Report a Side Effect
  • Contact
  • English
Home
Pharmaceuticals
  • Living with a Disease
    Living with a Disease
    Living with a Disease

    Quality of life is a mutual responsibility for all of us.

    • Overview
    • Cancer
      • TRK Fusion Cancer
      • Gastrointestinal Stromal Tumor
      • Liver Cancer
      • Prostate Cancer
      • Kidney Cancer
      • Breast Cancer
      • Thyroid Cancer
      • Virtual Press Room
        • HCC Virtual Media Briefing
        • ESMO Global Educational Webinar
    • Cardiovascular & Kidney Diseases
      • Thrombosis
      • Heart Attack
      • Chronic Kidney Disease
      • Heart Failure
      • High Blood Pressure
      • Stroke & Atrial Fibrillation
      • Diagnosing Heart Disease
    • Eye Conditions
      • Diabetic macular edema
      • Age-related Macular Degeneration
    • Hemophilia
    • Women's Healthcare
      • Contraception
      • Heavy Menstrual Bleeding
      • Menopausal Complaints
      • Endometriosis
      • Uterine Fibroids
      • Acne Therapy
    • Other Diseases
      • Pulmonary Hypertension
  • Innovation
    Innovation
    Innovation

    For over 120 years, Bayer has been researching and developing innovative medications and new therapeutic approaches that help make a difference to people’s lives.

    • Overview
    • Technologies
      • RNA interference
      • High-throughput screening
      • Digitalization in drug discovery
      • PROTACs
      • Diagnostic imaging
    • Trends
      • AAV Therapeutics
      • Cell Therapy - Stem Cells
      • Pharmacogenetics
      • Targeted-thorium Conjugates
      • Precision medicine
      • Biomarkers
      • AI in Pharma
    • Development Pipeline
      • Pipeline Insights
    • Clinical Trials
      • Ethics in Clinical Trials
      • FAQ
      • Transparenz-Richtlinie
      • Zugang zu Medikamenten
  • Partnering
    Partnering
    Partnering

    Bayer is a reliable and flexible partner who can help you take your work to the next stage and make the most out of its potential.

    • Overview
    • Why we Partner
    • Areas of Interest
    • Partnering With us
      • Forms of Collaboration
      • Chemical Probes for Open Access
    • Blog Partnering Insights
    • Where to Meet us
  • Who we are
    Who we are
    Who we are

    We are committed to the principles of sustainable development. With our products we aim to improve people's quality of life.

    • Overview
    • Our Engagement
      • Patient organization
      • Patient Engagement
      • #WeWontRest
      • Tropical Diseases
      • Family Planning
      • Healthy Aging
    • Global Health Policy
    • Newsletter
English
German
Mobile Navigation

Breadcrumb

  1. Home
  2. Search

Error message

English
German

Pagination

  • Previous page Previous
  • Page 1 /
  • Current page 2 /
  • Page 3 /
  • Page 4
  • Next page Next
11 - 20 of about 189 Documents
Chinese girl running on the beach
Healthy China 2030: China’s Healthcare Journey
The World Bank’s joint report with the Chinese government found that, without health care reform, health spending would increase to USD 2.5 trillion in 2035, up from USD 543.5 billion in 2014.
https://pharma.bayer.com/healthy-china-2030-chinas-healthcare-journey
Scientist in a labor
A Look at the Chinese Market
China is one of the largest pharmaceutical markets in the world - and a field of tension between unique to disruptive medical innovations and generic products.
https://pharma.bayer.com/look-chinese-market
Elevated highway in China
Healthy China 2030: Pooled Procurement Price Pressure
As part of Healthy China 2030, the Chinese government has opted to ramp up pressure on reimbursement negotiations and procurement processes.
https://pharma.bayer.com/healthy-china-2030-pressure-prices-under-pooled-procurement
Chinese doctor
Healthy China 2030: Strategy to Tackle Cancer
Cancer is on the rise in China. In 2014, the country saw 2.3 million deaths from the disease and 3.8 million new cases, accounting for more than one fifth of premature deaths and more than a quarter of new cancer cases worldwide.
https://pharma.bayer.com/healthy-china-2030-spotlight-chinas-strategy-tackle-cancer
Shangai_1
Healthy China 2030: Valuing Innovation in a Legal Framework
Since last year, the Chinese government has issued several announcements that enforce the protection of intellectual property (IP).
https://pharma.bayer.com/healthy-china-2030-valuing-innovative-cancer-medicines-chinas-legal-framework
healthy old man with his grandson
Healthy Heart For Healthy Aging
In an era with unprecedented longevity and declining birth rates, we are approaching a future defined by more people aged over 60 than under 15 for the first time in human history.
https://pharma.bayer.com/healthy-heart-healthy-aging
Intersection full of passengers in Japan
Japan: Protect Innovation to Protect Patients
After a year-long debate, the Japanese government is on the cusp of announcing their final decision on the reform of its drug pricing system.
https://pharma.bayer.com/japan-protect-innovation-protect-patients
Female_doctor_speaking_to_the_patient
Our Vision For Advancing Innovation in Europe
At Bayer Pharmaceuticals, we focus on researching, developing specialty-focused innovative medicines that provide significant clinical benefit and value in areas of high unmet medical need such as cardiology and oncology.
https://pharma.bayer.com/our-vision-advancing-innovation-europe
Female_patient_with_a_nurse
Pharmaceutical Innovation in Japan­: Rising Concern
Japan is an aging society and the prevalence of cancer and cardiovascular diseases is increasing.
https://pharma.bayer.com/rising-concerns-pharmaceutical-innovation-japan
Safeguarding Innovation in Europe
Safeguarding Innovation in Europe
Intellectual Property (IP) protection is the lifeblood of the research-based pharmaceutical industry.
https://pharma.bayer.com/safeguarding-innovation-europe

Pagination

  • Previous page Previous
  • Page 1 /
  • Current page 2 /
  • Page 3 /
  • Page 4
  • Next page Next
11 - 20 of about 189 Documents
  • Living With a Disease
    • Cancer
    • Cardiovascular & Kidney Diseases
    • Eye Conditions
    • Hemophilia
    • Other Diseases
  • Innovation
    • Technologies
    • Trends
    • Development Pipeline
    • Clinical Trials
  • Partnering
    • Why we Partner
    • Areas Of Interest
    • Partnering With us
    • Where to Meet us
  • Who we are
    • Our Engagement
    • Global Health Policy
Get in Touch
Do you have any queries or comments about our website, our products or any of our services?
Contact Us
Report A Side Effect

Follow Us

Copyright © Bayer AG

  • Conditions of use
  • Privacy statement
  • Imprint